Valuation: Teva Pharmaceutical Industries Ltd (ADR)

Market Cap 35.11B 30.76B 28.56B 26.24B 49.45B 3,388B 50.18B 340B 133B 1,658B 132B 129B 5,726B P/E 2026 *
37.2x
P/E 2027 * 16.4x
Enterprise Value 46.27B 40.54B 37.64B 34.58B 65.17B 4,465B 66.13B 448B 175B 2,185B 174B 170B 7,547B EV / Sales 2026 *
2.78x
EV / Sales 2027 * 2.53x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Teva Pharmaceutical Industries Ltd (ADR)

Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 69 2008-12-31
Chairman 78 2017-02-05
Director/Board Member 65 2015-08-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 36.5B
-1.05%+0.55%+49.79%+151.71% 1,048B
+2.00%+3.49%+52.22%+50.20% 603B
-1.09%+3.76%+35.37%+76.22% 452B
-0.42%+0.67%+30.81%+21.05% 327B
-0.16%+2.74%+36.02%+37.33% 283B
+1.68%+1.08%+22.70%+17.94% 259B
-1.40%-3.34%-24.63%-42.39% 219B
-0.05%+2.16%+19.75%+55.89% 198B
+0.05%-1.03%+18.31%+61.63% 162B
Average -0.25%+1.78%+26.70%+47.73% 394.63B
Weighted average by Cap. -0.47%+1.86%+35.85%+72.54%

Financials

2026 *2027 *
Net sales 16.64B 14.58B 13.53B 12.43B 23.43B 1,605B 23.78B 161B 63.1B 785B 62.45B 61.1B 2,714B 17.23B 15.1B 14.02B 12.88B 24.27B 1,663B 24.63B 167B 65.36B 814B 64.69B 63.29B 2,811B
Net income 1.31B 1.15B 1.06B 979M 1.84B 126B 1.87B 12.69B 4.97B 61.81B 4.91B 4.81B 214B 2.46B 2.16B 2B 1.84B 3.47B 238B 3.52B 23.87B 9.34B 116B 9.25B 9.05B 402B
Net Debt 11.16B 9.78B 9.08B 8.34B 15.72B 1,077B 15.95B 108B 42.34B 527B 41.9B 41B 1,821B 8.41B 7.37B 6.84B 6.28B 11.84B 811B 12.01B 81.46B 31.88B 397B 31.56B 30.88B 1,371B
Logo Teva Pharmaceutical Industries Ltd (ADR)
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-